Showing 31-40 of 44 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Novel insulin formulations for pumps | Stanford University | Yanxian Zhang | Improving Lives | 01-March-2023 to 28-February-2026 | $243,986.00 |
| Development of Low Cost, High Precision Nano Pumps for Insulin Delivery | Torramics Inc. | Sergey Gimelshein | Improving Lives | 01-March-2023 to 31-August-2026 | $1,493,212.43 |
| Development of a Microfluidic Patch Pump for Next-Generation Wearable Artificial Pancreas Systems | University of California, Santa Barbara | Sumita Pennathur | Improving Lives | 01-May-2023 to 30-April-2026 | $1,065,254.36 |
| Real time monitoring of a cell therapy product to assess and modify transplant health post-engraftment in patients with type 1 diabetes | Minutia | Katy Digovich | Cures | 01-November-2022 to 30-November-2025 | $1,198,600.00 |
| Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial | University of California, San Diego | Charles Ginsberg | Improving Lives | 01-November-2022 to 31-October-2026 | $1,356,726.45 |
| Ultrafast Insulin-Pramlintide Co-formulations | Stanford University | Eric Appel | Improving Lives | 01-September-2022 to 31-August-2025 | $795,000.00 |
| Reducing the Burden of Type 1 Diabetes Using Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances | University of California, San Diego | Schafer Boeder | Improving Lives | 01-July-2022 to 30-June-2027 | $749,956.58 |
| Transcriptional memory in human islet organogenesis | Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) | Eiji Yoshihara | Cures | 01-April-2022 to 31-March-2027 | $749,995.50 |
| A smart Semiconductor based Continuous Diabetes Monitoring Platform | Integrated Medical Sensors Inc | Muhammad Mujeeb-U-Rahman | Improving Lives | 01-June-2022 to 07-November-2025 | $500,000.00 |
| Microneedle Sensor for Simultaneous Continuous Monitoring of Ketone and Glucose | University of California, San Diego | Joseph Wang | Improving Lives | 01-October-2022 to 30-April-2026 | $799,998.91 |